1. Home
  2. CBT vs LGND Comparison

CBT vs LGND Comparison

Compare CBT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabot Corporation

CBT

Cabot Corporation

N/A

Current Price

$67.53

Market Cap

3.8B

Sector

Industrials

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

N/A

Current Price

$198.39

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBT
LGND
Founded
2019
1987
Country
United States
United States
Employees
N/A
68
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CBT
LGND
Price
$67.53
$198.39
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$70.00
$245.00
AVG Volume (30 Days)
379.7K
149.2K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
1.37
N/A
Revenue
$3,713,000,000.00
N/A
Revenue This Year
N/A
$0.74
Revenue Next Year
$2.89
$19.04
P/E Ratio
$49.47
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$58.33
$93.58
52 Week High
$84.89
$227.92

Technical Indicators

Market Signals
Indicator
CBT
LGND
Relative Strength Index (RSI) 32.71 49.78
Support Level $65.48 $198.52
Resistance Level $69.75 $207.72
Average True Range (ATR) 2.11 10.01
MACD -1.05 1.53
Stochastic Oscillator 12.20 41.26

Price Performance

Historical Comparison
CBT
LGND

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: